Alcohol Hepatitis Epidemiology Forecast Report 2017-2030

Dublin, January 08, 2021 (GLOBE NEWSWIRE) – Added Report “Alcohol Hepatitis Prediction – Epidemiology to 2030” ResearchAndMarkets.com’s offering.

This report ‘Alcoholic Hepatitis – Epidemiology Forecast to 2030’ delivers an in-depth understanding of the disease, the epidemiology of Alcoholic Hepatitis in the 7MM, ie, the United States, EU5 (Germany, Spain, Italy, the France, and the United Kingdom), and Japan.

Epidemiological Perspective

This section covering the Epidemiology of Alcoholic Hepatitis provides insights into a pool of historical and routine patients and projected trends for all seven major countries. The alcohol hepatitis epidemiological data are analyzed through all possible regions to gain a better understanding of the disease status in 7MM. This section covers epidemiological data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps with identify the causes of current and projected trends by analyzing multiple studies, analyzing reports, and the opinions of key opinion leaders.

Detailed explanation of epidemiology

Hepatitis Alcohol Epilepsy Covered in the report provides a historical epidemiological setting of Hepatitis Alcoholism as well as predicted in the 7MM covering the United States, EU5 countries (A Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

The report also provides the epidemiological trends observed in the 7MM during the study period, along with the assumptions undertaken. The measured data are presented with relevant charts and graphs to give a clear view of the epidemiology at first glance.

Report the top events

  • 11-Year Estimate of the Epidemiology of Alcoholic Hepatitis
  • Cover 7MM
  • Complete Cases of Alcohol Hepatitis
  • Diagnosed cases of alcoholic hepatitis
  • Specific Cases of Alcoholic Hepatitis
  • Cases specific to alcoholic hepatitis

Key Assessments

  • Patient separation
  • Danger of disease and cattle
  • Disease risk with separation
  • Factors driving growth in a particular patient population

Key topics covered:

1. Key views

2. Executive Summary of Alcoholic Hepatitis

3. SWOT analysis for alcoholic hepatitis

4. Alcoholic Hepatitis: An Overview of Disease
4.1. Introduction
4.2. Alcoholic liver disease
4.3. Etiology
4.4. Signs and Symptoms
4.5. Clinical demonstration
4.6. Histopathology
4.7. Pathogenesis
4.8. Prognosis
4.9. Risk factors
4.10. Diagnosis
4.10.1. Differential diagnosis

5. Epidemiology and Patient Population
5.1. Key Findings

6. Epidemiology 7MM
6.1. Opinions and Philosophy
6.2. Moderate to severe diagnosis of alcoholic hepatitis (AH) at 7MM
6.3. United States
6.3.1. Total Cases of Alcohol Hepatitis (AH) in the United States
6.3.2. Diagnostic Cases of Alcoholic Hepatitis (AH) in the United States
6.3.3. Specific Sex Cases of Alcoholic Hepatitis (AH) in the United States
6.3.4. Specific Cases of Alcohol Hepatitis (AH) in the United States
6.4. Germany
6.5. France
6.6. Italy
6.7. Spain
6.8. United Kingdom
6.9. Japan

7. Treatment of alcoholic hepatitis
7.1. Handling Instructions

8. Unmet needs

9. Organizations contribute to AH

10. Case studies
10.1. Alcoholic hepatitis – the case for intensive management
10.2. Case of major alcoholic hepatitis treated with granulocytapheresis
10.3. Severe alcoholic hepatitis: Abnormal presentation with marked elevated alkaline phosphatase
10.4. Alcoholic hepatitis with unexpected histology: A Case Report

11. Views of KOL

12. Appendix

For more information about this report, visit https://www.researchandmarkets.com/r/uzkrvd

Research and Markets also offers Custom Search services providing targeted, complete and unique search.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

.Source